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a b s t r a c t
Tako-tsubo cardiomyopathy is a heart disease that imitates acute myocardial infarction.
Classical ﬁndings include apical and mid segment hypokinesia. However, it may have
different appearance than was originally described.
In our case report we describe a case of woman with tako-tsubo cardiomyopathy (TTC),
who was admitted to hospital after a stressful event because of chest pain, with normal
coronary angiogram and with mild elevation of Troponin-I level.
Electrocardiogram corresponded with non-Q myocardial infarction of inferior wall.
Following left ventriculography, echocardiography and magnetic resonance, impaired
contractility of the basal part of inferior wall was noticed, together with good global ejection
fraction. Full recovery was attained in ﬁve weeks after the onset.
This impairment of left ventricle is not typical for TTC. In our patient, the basal part of left
ventricle was affected, and not the apex as it is usually seen in TTC. This ﬁnding corresponds
to rare ‘‘inverted’’ form of TTC. Another atypical feature is segmental involvement that,
moreover, covered the inferior wall. This morphological pattern, according to our best
knowledge, has not yet been described in literature.
Pathophysiology, epidemiology and clinical signiﬁcance are shortly reviewed in the paper.
# 2013 The Czech Society of Cardiology. Published by Elsevier Urban & Partner Sp. z o.o.
All rights reserved.




Tako-tsubo cardiomyopathy (TTC) is relatively recently
described disease, which imitates clinical, laboratory and
electrocardiographical (ECG) ﬁndings in acute myocardial* Correspondence to: Jugoslavska 18, 61300 Brno, Czech Republic. Te
E-mail address: kadir@seznam.cz (A.Q. Negahban).
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0010-8650/# 2013 The Czech Society of Cardiology. Published by Elseinfarction (AMI). The disease was ﬁrst described by Japanese
authors in 1991 [1,2]. The term ‘‘tako-tsubo’’ corresponds to
the typical shape of left ventricle, which resembles to
traditional Japanese octopus trap (‘‘tako’’=octopus, ‘‘tsubo’’=
pot) [2]. Typically, it is characterized by ball-shaped ballooning
of anterior wall and the apex. Low contractility in this area isl.: +420 723715164.
vier Urban & Partner Sp. z o.o. All rights reserved..
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[3–5]. In approximately one quarter of the patients, there is
also similar impairment of the right ventricle [6,7].
An emotional or physical stress is often initiating factor of
TTC [8], however, in many cases, immediate cause is not
apparent. Most of the patients are women in post-menopausal
age [3,8,9]. Potentially life-threatening complications include
cardiogenic shock, arrhythmias or pulmonary oedema [4], in-
hospital mortality is about 2% [10]. Long-term prognosis is
mostly favourable with complete resolution [3,11].
The diagnostic criteria according to Mayo Clinic are as
follows:
1. New abnormalities on ECG (ST-segment elevation and/or T-
wave inversion) and/or cardiac troponin elevation.
2. Transient (reversible) akinesia or dyskinesia of the left
ventricular mid segments, eventually also with involve-
ment of the apex, independently of vascular distribution.
3. Absence of obstructive coronary artery disease at coronary
angiography.
4. Absence of myocarditis or pheochromocytoma.
Original criteria also included an absence of head injury
or intracranial haemorrhage. However, the wall motion
abnormalities in these cases, which are also known as
neurogenic stunned myocardium (NSM), likely share the
same pathogenetic mechanisms with the classical form of
TTC [8,12].
The condition of no coronary atherosclerosis has also
been put into question. The etiopathogenic mechanisms
leading to TTC can be basically present regardless the
presence or absence of coronary atherosclerosis [13]. From
the diagnostic point of view, this can be compared for
example to coincidence of ischaemic heart disease and
dilated cardiomyopathy: one disease, in principle, does not
exclude the other.
The terms ‘‘tako-tsubo cardiomyopathy’’, as well as
alternative name ‘‘apical ballooning syndrome’’ are being still
in use, in spite of many patients having abnormalities of
different parts of heart wall than the apex [11,14]. Other
synonymous terms are ‘‘stress cardiomyopathy’’ or ‘‘broken-
heart syndrome’’. The disease is responsible for 1–2% of cases
diagnosed as acute coronary syndrome [15], it is thus
necessary to bear it in mind in differential diagnostics of
acute chest pain with negative ﬁndings on coronary arterio-
gram and impaired ejection fraction.
Case report
We present a case of 56 year old female with positive family
history of ischaemic heart disease, post hysterectomy and
adnexectomy due to cervical carcinoma at 34 years; she had
migraine with occasional attacks, but otherwise no disease.
She was working as a secretary in public services, smoking 5–6
cigarettes daily and drinking 2–3 cups of coffee per day, she
denied drinking alcohol.
The patient presented to the Emergency with chest pain
and hypertension after a car accident when she was annoyed
due to indecency of the second participant in this accident.Paramedics were called by her husband, who measured the
blood pressure of 180/120 mmHg, regular heart rate of 80 beat
per minute, oxygen saturation of 97%. She was given captopril
12.5 mg sublingually and diazepam 5 mg intravenously and
she was immediately transferred to the nearest hospital for
further management.
Laboratory tests on admission showed slight elevation of
Troponin-I level of 0.48 micrograms per litre (mg/L) and reached
the maximum of 0.72 mg/L within 24 h, while normal values do
not exceed 0.014 mg/L. Neither creatine kinase (CK), nor its
isoenzyme CK MB was elevated, as there were no other
laboratory abnormalities noticed on admission.
Transthoracic echocardiography (TTE) was performed on
admission (Fig. 1a and b) with the ﬁnding of posterobasal
hypokinesis of the inferior wall and slightly decreased left
ventricular systolic function with left ventricular ejection
fraction (LVEF) of 48%. Electrocardiogram on admission
showed Q wave in lead III, aVF with negative T wave in lead
I, III, aVF and in lead V5–V6 (Fig. 2a and b) with normal AV
conduction. The patient was given clopidogrel, acetyl salicylic
acid (ASA) and low molecular weight heparin and she was
transferred to the cath lab of St Anne's University Hospital
in Brno.
Coronary angiography was performed and no stenosis or
other impairment of coronary arteries was detected (Fig. 3a
and b). On ventriculography, posterobasal hypokinesis of
inferior wall was demonstrated (Fig. 3c and d), decreased left
ventricular systolic function with LVEF of 45%. A suspicion for
an atypical pattern of tako-tsubo cardiomyopathy was
expressed. In differential diagnosis, thrombembolic AMI or
AMI following coronary vasospasm could have been hypothe-
sized.
Two days later the patient was discharged with following
medication: metoprolol succinas 25 mg once daily and ASA
100 mg once daily. ECG and TTE on discharge showed the same
ﬁnding as was seen on admission. Patient was followed up for
next 2 months.
Second TTE (Fig. 1c and d) was performed 2 weeks after
discharge and it showed only slight posterobasal hypokinesis
of inferior wall. In the same time, a cardiac magnetic
resonance imaging (Fig. 4a–d) was performed in order to get
more information about the myocardial muscle. The exami-
nation conﬁrmed the posterobasal hypokinesis of inferior
wall. No scar in the myocardium, as a sign of AMI, was found in
the late gadolinium enhancement.
Unfortunately the patient has not been agreeable to
undergo the second MRI scan in order to assess if there are
any new changes in the myocardium.
We assumed that if the late gadolinium enhancement had
not shown any scar within the myocardium it is fairly
convincing that there was no myocardial infarction.
The third TTE (Fig. 1e and f) was performed by the same
echocardiographer 5 weeks after discharge.
Normal segmental and global left ventricular function was
found. ECG curve showed no Q wave or T wave inversion in
inferior leads (Fig. 2c).
The ﬁndings in cardiac MRI, as well as the complete
resolution of ventricular wall motility and rearrangement of
the ECG curve, were thus consistent with the ﬁrst proposed
diagnosis, i.e. TTC.
Fig. 1 – Echo figures: (a) Echocardiography on admission, parasternal short axis (PSAX) at the level of papillary muscles, end-
diastole – area of hypokinesis (arrow); (b) Echocardiography on admission, PSAX at the level of papillary muscles, end-systole
– area of hypokinesis (arrow); (c) Echocardiography, 2 weeks after discharge, PSAX at the level of papillary muscles, End-
diastole – area of hypokinesis (arrow); (d) Echocardiography, 2 weeks after discharge, PSAX at the level of papillary muscles,
end-systole – area of hypokinesis (arrow); (e) Echocardiography, 5 weeks after discharge, PSAX at the level of papillary
muscles, end-systole – no hypokinesis – complete recovery; (f) Echocardiography, 5 weeks after discharge, PSAX at the level
of papillary muscles, end-diastole – no hypokinesis – complete recovery.
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This case study is interesting notably for an atypical localiza-
tion of myocardial hypokinesis, where the basal part of left
ventricle was involved. The form of TTC with basal involve-
ment, usually together with apical hyperkinesia, is known as
‘‘inverted tako-tsubo’’ and is only rarely described in the
literature [16]. In recent multi-centre study, published in
Journal of the American Medical Association and comprising
239 patients from 7 centres in Europe and North America, this
form was present only in 2 cases. Typical form with apical
involvement was present in 197 patients (82%), mid segment
involvement in 40 patients (17%) and right ventricle involve-
ment in 81 patients (34%) [14]. In our case, there was a
hypokinesia of the basal part of inferior wall. This feature is
also atypical, as in segmental involvement, the hypokinesia of
anterior wall is usually present [16]. Absence of apical
hyperkinesia could be explained by a delay between the onset
of chest pain and ventriculography, which was almost 48 h.
Appearance and disappearance of Q waves is common in
TTC. In most cases, it involves chest leads V2–V4 and is caused
by electrical hyperactivity of basal left ventricle compared to
the apex. In our case, when posterobasal segments were
affected, the Q waves in III and aVF corresponded with relativeapical hyperactivity. Rapid disappearance of Q waves (in days),
observed in our case, is unique for TTC and probably
corresponds with the normalization of electric stunning [17].
The cases of TTC were described e.g. during anaesthesia
[18], in systemic lupus erythematodes [19], or during sepsis
caused by Pseudomonas aeruginosa [20]. The same picture can
be seen in some cases of NSM after subarachnoideal
haemorrhage, as well as in other diseases of central nervous
system. This fact points to very fuzzy borderline and large
intersection between both diseases [12].
Exact pathophysiology of TTC is still a subject of discus-
sions. First studies were proposing multivessel coronary
vasospasm as the most important mechanism. This, however,
has not been conﬁrmed by subsequent research [9]. Further-
more, magnetic resonance ﬁndings do not show the presence
of necrosis, despite of elevated concentrations of cardiac
troponin [21]. These results are in good accordance with our
case, where the tissue saturation in late gadolinium enhance-
ment was not apparent.
In present research, most of the authors favour catechol-
amine overload as the key contributor to TTC development
[15]. Lyon et al. [22] suggested that changes in post-receptor
cascade of b2-adrenergic receptors should play the principal
role. Under normal conditions, after adrenaline binds the
b2-receptor, adenylatecyklase is activated via Gs proteins. This
Fig. 2 – ECG figures: (a) ECG on admission, extremity leads Q wave in III, aVF (arrows); (b) ECG on admission, chest leads
negative T wave in V5–V6 (arrows); (c) ECG 5 weeks after discharge, all leads, no Q wave or T wave inversion apparent.
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inotropic effect of catecholamins. On the other hand, in high,
‘‘supraphysiological’’ concentrations of adrenaline, the nega-
tively inotropic effect via Gi proteins prevails [23]. The reason
of this ‘‘switch’’ is probably the phosphorylation of b2-receptorby protein kinase A [24]. This process can primarily serve as
protection against pro-apoptotic effects of catecholamines
mediated by b1-receptors [25]. b1-mediated apoptosis of
cardiomyocytes could be responsible for elevated troponin
levels in the blood.
Fig. 3 – Coronarography figures: (a) Selective left coronary angiogram, LAD and RC without stenosis; (b) Selective right
coronary angiogram, ACD without stenosis; (c) Retrograde left ventriculography, diastole; (d) Retrograde left
ventriculography, systole, posterobasal hypokinesis of the inferior wall.
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localization of myocardial contractility involvement with
apical ballooning. In basal area, there are more sympathetic
nerve endings compared to the apex [26]. The same distribu-
tion is present also in dog hearts, where higher concentration
of b-receptors in the apex compared to the base has been
found [27]. During adrenaline overload, this could lead to
higher response of apical parts of the heart. On the other hand,
recently published study comparing b-receptor density in
patients after AMI and healthy subjects pointed to their lower
concentration in the apex [28]. In all cases, none of the
mentioned studies distinguished between b1 and b2 receptors.
Another possible mechanism could be microvascular
vasoconstriction. This effect is mediated by both a1 and a2-
adrenergic receptors [29]. In TTC patients, abnormal Throm-
bolysis In Myocardial Infarction (TIMI) frame count was found,
indicating impaired microcirculatory ﬂow [30]. There is also an
evidence of impaired myocardial perfusion in contrast
echocardiography [31] and reversible impairment of coronaryﬂow reserve in positron emission tomography [32]. Indirect
support of this mechanism comes from an experiment with
animal model of TTC, where the administration of both b-, and
a-blockers was necessary to prevent pathological changes [33].
It is thus probable that in TTC development, both mechanisms
are relevant.
A typical feature of TTC is unequal distribution of incidence
between both sexes. About 90% of patients with TTC are
women, and postmenopausal women are at highest risk
[3,8,9]. This fact continues to be a subject of investigation. Most
likely, variable catecholamine concentration during women's
life takes place here. Young women have lower adrenaline and
noradrenaline plasmatic concentration compared to men, but
its increase with age is higher [34]. Lower levels of oestrogens
after the menopause that are linked to higher sympathetic
activity, may play the role [35]. However, in other study, the
increase of catecholamine levels with age was independent on
menopausal status [34]. Moreover, oestrogens protect the
myocardium against high doses of catecholamins by various
Fig. 4 – MRI figures: (a) Cardiac magnetic resonance image (CMRI), T2 SSFP (TrueFISP), short axis view (SAX), area of
hypokinesis (arrow); (b) CMRI, T1 IR (inversion recovery) sequence after injection of contrast medium (gadolinium), short axis
view (SAX), no late gadolinium enhancement finding; (c) CMRI, T2 SSFP (TrueFISP), three chamber view, end-diastole, area of
hypokinesis (arrow); (d) CMRI, T2 SSFP (TrueFISP), three chamber view, end-systole, area of hypokinesis (arrow); (e) CMRI, T1
IR (inversion recovery) sequence after injection of contrast medium (gadolinium), three chamber view, no late gadolinium
enhancement finding.
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age may lead into its hypersensitivity for adrenergic
stimulation [36]. It can be expected, that similar mechanism
might be employed also in other forms of catecholamine-
induced stunned myocardium, as in patients with subar-
achnoideal haemorrhage, where lower plasmatic level of
oestrogens was associated with impaired myocardial con-
tractility [37].
Conclusion
In our case report we describe a case of unusual, inverted form
of tako-tsubo cardiomyopathy with the impairment of basal
part of inferior wall. It is a rare form of often overlooked
disease, that may imitate clinical, electrocardiographically
and laboratory ﬁndings in acute myocardial infarction.
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